Phillips 66 (PSX) — Q2 2026 Earnings Preview

Company

Phillips 66

Ticker

PSX (NYSE)

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Earnings Date

August 5, 2026 — 12:00 PM ET

Prepared

August 4, 2026

Last Earnings

April 29, 2026 (Q1 2026)

1. Earnings Preview

Key Takeaway: The setup into PSX’s Q2 print is strongly bullish — consensus EPS of $7.68 is already well above the post-Q1 baseline of $6.04 and has been revised sharply higher through the quarter, yet peer prints from VLO and MPC suggest the refining margin environment was even stronger than the street modeled, pointing to a likely beat; the single biggest swing factor is the mark-to-market reversal on PSX’s short derivative hedges, which management guided would recover ~$500M by year-end.

The bar heading into Q2 is high in absolute terms but may still be beatable given the extraordinary refining margin environment. Brent crude averaged ~$90/bbl in Q2 driven by the U.S.-Israeli conflict with Iran and the effective closure of the Strait of Hormuz, which simultaneously boosted crack spreads and tightened global product supply — VLO reported its highest-ever Q2 profit at $12.54/share vs. $10.12 consensus, and MPC posted $17.73/share vs. $13.73 consensus, both massive beats. Management’s tone on the Q1 call was unambiguously bullish: Brian Mandell stated “this is the time to be bullish U.S. refining” and guided Q2 crude utilization in the “low to mid-90s” with turnaround expense of $120–$150M — a lighter maintenance quarter than Q1’s $178M. Estimate revisions have been sharply positive: Q2 EPS consensus moved from $6.04 (5 days post-Q1 print) to $7.68 currently, a +27% upward revision, while FY2026 EPS moved from $16.97 to $21.71 over the same window, reflecting the sector-wide margin uplift. The stock has re-rated materially since the Q1 print (+22% from $173.49 to ~$211), driven almost entirely by earnings estimate upgrades rather than multiple expansion — NTM EV/EBITDA has actually compressed from ~8.4x to 7.4x over six months, suggesting the stock is not pricing in a beat. The key wildcard is the magnitude of mark-to-market hedge reversal: PSX guided ~$500M of the $839M Q1 MTM loss to reverse by year-end based on the forward curve, and any Q2 reversal would be additive to already-strong operational results; conversely, renewed commodity price spikes (e.g., Hormuz re-escalation) could create fresh MTM losses that obscure an otherwise strong operational quarter.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a high bar in absolute terms but likely still beatable given peer prints — Refining Adjusted EBITDA ($2.92B consensus) is the bigger swing factor, as it captures both the margin environment and PSX’s commercial capture rate, which hit a record 138% in Q1.

Table 1 — Q2 2026 Current Quarter Snapshot (All Key KPIs)

KPI

Q1 2026 Actual

Q2 2025 Actual

Q2 2026 Consensus

YoY Change

Q2 2026 Guidance

Cons. vs. Guidance

EPS — Diluted Operating ($)

$0.49

$2.38

$7.68

+223% YoY

No specific EPS guidance

N/A

Refining Adj. EBITDA ($M)

$423M

$835M

$2,923M

+250% YoY

No specific segment guidance

N/A

Midstream Adj. EBITDA ($M)

$865M

$991M

$998M

+0.7% YoY

On track to $4.5B run rate by end-2027

N/A (no quarterly target)

Refinery Crude Utilization (%)

95.0%

104.3%

100.1%

-4.2pp YoY

Low-to-mid 90s

~+5pp above guidance midpoint

Controllable Cost/Bbl — Refining ($)

$7.08

$5.03

$5.97

+18.7% YoY

$5.50/bbl target by end-2027

+8.5% above 2027 target

Refining Turnaround Expense ($M)

$178M

N/A — not in VA

N/A — not in VA

N/A

$120–$150M

N/A (no consensus)

Corporate & Other Costs ($M)

$451M (adj. pretax loss)

N/A — not in VA

N/A — not in VA

N/A

$430–$450M

N/A (no consensus)

Sources: Visible Alpha Consensus and Actuals Data (EPS — Diluted — Operating, Refining Adj. EBITDA, Midstream Adj. EBITDA, Utilization, Controllable Cost/Bbl); PSX Q1 2026 Earnings Call transcript for guidance figures.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

EPS — Diluted Operating ($)

Quarter

Reported

Consensus

Surprise %

Result

Q1 2026

$0.49

-$0.45

N/M (swing to profit)

Beat

Q4 2025

$2.47

$2.17

+14.0%

Beat

Q3 2025

$2.52

$2.15

+17.2%

Beat

Q2 2025

$2.38

$1.68

+41.7%

Beat

Q1 2025

-$0.90

-$0.72

-24.7%

Miss

Q4 2024

-$0.15

-$0.23

+37.0%

Beat

Q3 2024

$2.04

$1.65

+23.6%

Beat

Q2 2024

N/A — not in VA window

N/A

N/A

N/A

Refining Adjusted EBITDA ($M)

Quarter

Reported ($M)

Consensus ($M)

Surprise %

Result

Q1 2026

$423M

-$71M

N/M (swing to positive)

Beat

Q4 2025

$1,019M

$927M

+9.9%

Beat

Q3 2025

$874M

$870M

+0.5%

In-Line

Q2 2025

$835M

$659M

+26.7%

Beat

Q1 2025

-$481M

-$494M

+2.6% (smaller loss)

Slight Beat

Q4 2024

-$324M

-$375M

+13.6% (smaller loss)

Beat

Q3 2024

$163M

$133M

+22.6%

Beat

Q2 2024

N/A — not in VA window

N/A

N/A

N/A

Pattern: PSX has beaten on both EPS and Refining EBITDA in 6 of the last 7 reportable quarters, with the sole miss on EPS in Q1 2025 driven by mark-to-market losses — the same dynamic that depressed Q1 2026 reported EPS but was correctly identified as non-cash by the market. The consistent beat pattern on Refining EBITDA reflects PSX’s commercial capture advantage.

Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance has not been formally revised since the Q1 2026 earnings call, but management’s tone has shifted from “confident” to “actively bullish” across refining, chemicals, and renewable fuels — the Western Gateway Pipeline FID is the most significant pending catalyst.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 29)

Revised Guidance

Current Consensus

Note

Q2 Worldwide Crude Utilization

Low-to-mid 90s

100.1%

Consensus above guidance midpoint; no post-earnings revision

Q2 Chemicals O&P Utilization

Low 80s

N/A — not in VA

Driven by Middle East JV uncertainty; no revision

Q2 Turnaround Expense

$120–$150M

N/A — not in VA

Lighter than Q1’s $178M; no revision

Q2 Corporate & Other Costs

$430–$450M

N/A — not in VA

No revision; includes LA Refinery decommissioning costs

Total Debt Target (YE 2026)

~$19B

N/A

Path: collateral release + OCF + working capital normalization; no revision

Total Debt Target (YE 2027)

$17B

N/A

Reaffirmed; ~$1.5B annual reduction in 2026 and 2027

Shareholder Return Policy

>50% of net operating cash flow

N/A

Unchanged; dividend raised 7% annualized in Q1

Midstream EBITDA Target (YE 2027)

$4.5B run rate

$3.91B FY2026 consensus

Confident delivery; Zeus Gas Plant & Coastal Bend Fractionator 3 FID’d May 2026 for 2028 startup

Western Gateway Pipeline FID

Mid-to-late summer 2026

N/A

2029 in-service date; JV with Kinder Morgan; FID imminent

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been revised sharply higher since the Q1 print — Q2 EPS consensus is up +27% and FY2026 EPS is up +28% from the post-Q1 baseline — reflecting the sector-wide margin uplift from Middle East supply disruptions; the gap between current consensus and initial guidance is entirely driven by the macro environment, not company-specific guidance changes.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 6, 2026)

Current Consensus (Aug 4, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Cons. vs. Guidance (%)

EPS — Diluted Operating (Q2 2026)

$6.04

$7.68

+27.2%

No specific guidance

No specific guidance

N/A

N/A

EPS — Diluted Operating (FY2026)

$16.97

$21.71

+27.9%

No specific guidance

No specific guidance

N/A

N/A

Refining Adj. EBITDA (Q2 2026)

$2,243M

$2,923M

+30.3%

No specific guidance

No specific guidance

N/A

N/A

Refining Adj. EBITDA (FY2026)

$6,588M

$7,899M

+19.9%

No specific guidance

No specific guidance

N/A

N/A

Midstream Adj. EBITDA (Q2 2026)

$999M

$998M

-0.1%

$4.5B run rate by YE 2027

Unchanged

N/A

N/A

Midstream Adj. EBITDA (FY2026)

$3,925M

$3,909M

-0.4%

$4.5B run rate by YE 2027

Unchanged

N/A

N/A

The revision trajectory tells a clear story: refining-driven estimates have surged +27–30% since the Q1 print, entirely macro-driven by the Iran conflict and Hormuz closure, while midstream estimates have been essentially flat — consistent with the stable, fee-based nature of that business. PSX does not provide specific EPS or segment EBITDA guidance, so there is no formal guidance vs. consensus gap to measure; the relevant comparison is the magnitude of estimate revision vs. the macro environment.

Source: Visible Alpha Consensus and Actuals Data (all estimate figures).

5. Stock Performance

Key Takeaway: PSX has outperformed XLE by ~+15pp since the Q1 print, driven almost entirely by earnings estimate upgrades (+27% on Q2 EPS, +28% on FY2026 EPS) rather than multiple expansion — NTM EV/EBITDA has actually compressed from ~8.4x to 7.4x over six months, suggesting the re-rating is durable and not sentiment-driven.

Since the Q1 2026 earnings date (April 29, 2026), PSX has risen approximately +22% (from $173.49 to ~$211.68 as of July 31, 2026), significantly outperforming XLE (+0.9%, from $59.03 to $59.55) and the S&P 500 (+5.0%, from $711.58 to $747.03). The stock’s outperformance vs. XLE reflects PSX’s higher operating leverage to refining margins relative to the broader energy ETF, which is weighted toward E&P names. Key inflection points: (1) early May — stock pulled back ~3% as oil prices dipped on Iran ceasefire hopes; (2) mid-June — stock dipped to ~$166 as crude prices fell on Hormuz reopening speculation; (3) July 8–17 — sharp re-acceleration (+24% in 10 trading days) as VLO and MPC pre-announced strong results and oil prices re-escalated on renewed U.S.-Iran strikes; (4) late July — modest consolidation as crude pulled back on ceasefire pause. The stock’s 12-month performance of +72% has been driven almost entirely by earnings growth, with NTM P/E compressing from ~15.9x to ~9.8x over the same period, confirming that the move is fundamentals-driven rather than multiple expansion.

Sector ETF used: XLE (Energy Select Sector SPDR Fund) — appropriate for PSX as a diversified downstream energy company. Stock price data sourced from Yahoo Finance.

PSX vs. XLE vs. S&P 500 — Indexed Performance Since Q1 2026 Earnings (Apr 29, 2026)

Date

PSX (Indexed)

XLE (Indexed)

SPY (Indexed)

Apr 29, 2026 (Base)

100.0

100.0

100.0

May 7, 2026

97.0

94.8

102.8

May 19, 2026

105.1

103.8

103.1

Jun 17, 2026 (trough)

96.4

92.6

104.1

Jul 17, 2026

119.2

97.7

104.5

Jul 31, 2026

122.0

100.9

105.0

Aug 4, 2026 (latest)

118.8

99.6

106.5

Note: Indexed to 100 at April 29, 2026 close. PSX: $173.49; XLE: $59.03; SPY: $711.58. Source: Yahoo Finance (Stock Price Data).

6. Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the extraordinary refining margin environment driven by the U.S.-Iran war and Strait of Hormuz closure, which has been the dominant driver of estimate revisions and stock performance; the Western Gateway Pipeline FID (expected mid-to-late summer) is the most significant company-specific catalyst pending.

7. Peer Commentaries / Read-Throughs

Key Takeaway: Peer commentary from Q2 2026 earnings calls (July–August 2026) is uniformly bullish on the refining macro outlook, with VLO and MPC both flagging that Q3 2026 margins and capture rates look stronger than Q2 — a direct positive read-through for PSX’s Q2 print and forward guidance.

Note: Only commentary from the last 60 days (June 5 – August 4, 2026) that explicitly concerns Q2 2026 results or the Q3 2026 / forward outlook is included below. Historical Q1 2026 result commentary from peers is excluded.

Valero Energy (VLO) — Q2 2026 Earnings Call, July 30, 2026

Marathon Petroleum (MPC) — Q2 2026 Earnings Call, August 4, 2026

HF Sinclair (DINO) — Q2 2026 Earnings Release, July 28, 2026

CVR Energy (CVI) — Q2 2026 Earnings Call, July 30, 2026

8. Insider Transaction Activity

Key Takeaway: Insider activity since the Q1 print is limited to planned 10b5-1 sales by the CFO and General Counsel — no discretionary open-market buys or unusual sale clusters; the one open-market purchase was by a newly appointed director, which is routine.

Name

Title

Transaction Type

Shares

Date

Note

Sutherland, Vanessa Allen

EVP, GC & Secretary

10b5-1 Planned Sale

3,523 shares

Jul 21, 2026

Pre-planned (plan est. Mar 17, 2026); routine; ~2% of holdings

Sutherland, Vanessa Allen

EVP, GC & Secretary

10b5-1 Planned Sale

563 shares

Jul 20, 2026

Pre-planned (same plan); tax withholding-related tranche

Mitchell, Kevin J.

EVP & CFO

10b5-1 Planned Sale

11,021 shares

Jul 9, 2026

Pre-planned; routine diversification; ~10% of holdings

Mitchell, Kevin J.

EVP & CFO

Open Market Sale

600 shares

May 11, 2026

Discretionary; small size; not flagged as 10b5-1

Mitchell, Kevin J.

EVP & CFO

Open Market Sale

29,400 shares

May 8, 2026

Discretionary; larger sale at ~$171/share; notable size but no 10b5-1 flag

Meyers, Kevin Omar

Director (newly appointed)

Open Market Buy

175 shares

May 6, 2026

Routine director purchase upon appointment; not a discretionary signal

Source: SEC Form 4 Filings Database (Insider Transaction Data). Note: The CFO’s May 8 sale of 29,400 shares at ~$171/share is the most notable transaction in size, but occurred shortly after the Q1 earnings print and is not flagged as a 10b5-1 plan — worth monitoring but not a clear negative signal given the stock has since risen ~24% from that level. The Form 144 filing by Sutherland on July 22 (intention to sell $743K) is consistent with the executed Form 4 sales.

9. Key Questions for the Call

  1. Mark-to-Market Hedge Reversal in Q2: How much of the $839M Q1 MTM loss reversed in Q2? Management guided ~$500M recovery by year-end based on the forward curve — what was the Q2 contribution, and what is the remaining expected reversal in H2?
  2. Refining Market Capture Rate: Q1 worldwide market capture hit a record 138%. What was Q2 capture, and how much of the commercial optionality (Jones Act waivers, time charters, global placement) that drove Q1 outperformance was available in Q2?
  3. Western Gateway Pipeline FID: Management guided FID “mid-to-late summer 2026” for a 2029 in-service date. Has FID been taken? What is the project cost, PSX’s equity share, and expected EBITDA contribution? KMI’s $1.75B notes offering — is this related?
  4. Debt Reduction Progress: Q1 debt rose to $27.1B from $19.7B due to margin collateral requirements. How much collateral has been released in Q2 as commodity prices normalized? Is the company on track for ~$19B by year-end 2026?
  5. WCS Differential Outlook: WCS spreads temporarily tightened due to Canadian wildfires/floods. Have they widened back out? MPC guided WCS to move north of $16/bbl by Q4 — does PSX agree, and what is the current sensitivity?
  6. Chemicals (CPChem) Q2 Performance and Q3 Outlook: Q2 guidance was low-80s O&P utilization due to Middle East JV uncertainty. What actually happened? Are the Middle East JV assets restarting, and what is the Q3 utilization outlook?
  7. Rodeo Renewable Fuels — Monetization Interest: Management indicated openness to asset monetization at Rodeo. With RIN values more than double 2025 levels and the facility running above nameplate, has interest from potential buyers increased? What is the current mid-cycle EBITDA target?
  8. Hormuz Reopening Scenario: Iran and Oman are reportedly working toward a Hormuz deal. How does PSX model the impact of a gradual reopening on refining margins, crude differentials, and the chemicals recovery timeline? Management has noted the process would be slow — what is the base case?
  9. Shareholder Returns in Q2: Q1 returns were $778M ($269M buybacks + $509M dividends). With strong cash generation in Q2, did buyback pace accelerate? Is the company on track for ~$2B in annual buybacks?
  10. Refining Controllable Cost Progress: Q1 controllable cost was $6.21/bbl ($5.80s normalized for natural gas), within striking range of the $5.50/bbl 2027 target. What was Q2 cost/bbl, and are the 200+ active initiatives delivering the expected $0.15–$0.20/bbl structural reduction?

Appendix: Valuation Context

PSX trades at 7.4x NTM EV/EBITDA vs. the refining peer group median of approximately 6.0–6.5x, representing a ~15% premium. This premium is justified by PSX’s growing midstream earnings mix (~$4B stable EBITDA), improving cost structure, and commercial optionality. Over the past 12 months, PSX’s NTM EV/EBITDA has compressed from 8.76x to 7.37x (−15.9%), meaning the +72% stock return has been driven entirely by earnings growth, not multiple expansion. The stock’s NTM P/E of ~9.8x is at the low end of its historical range, suggesting further upside if the margin environment persists as management and peers expect.

Metric

PSX

1M Δ Multiple

3M Δ Multiple

12M Δ Multiple

NTM EV/EBITDA

7.37x

+1.4%

-3.3%

-15.9%

NTM P/E

9.83x

+1.6%

-4.8%

-38.1%

NTM P/FCF

10.01x

-1.6%

-10.9%

-35.1%

NTM EV/Sales

0.74x

+12.1%

+19.3%

+36.0%

NTM P/Book

2.31x

+10.4%

+6.7%

+29.7%

Source: Stock Performance Decomposition data (NTM consensus multiples as of August 4, 2026). Peer group: Oil & Gas Refining & Marketing (MPC, VLO, DINO, SUN, PBF, CVI, DKL, WKC, PARR, DK, VVV).